Skip to main content
SpringerLink
Log in

The three-step pretargeting approach reduces the human anti-mouse antibody response in patients submitted to radioimmunoscintigraphy and radioimmunotherapy

  • Letters to the editor
  • Published:
European Journal of Nuclear Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Schlom J. Basic principles and applications of monoclonal antibodies in the management of carcinomas: The Richard and Hinda Rosenthal Foundation Award Lecture.Cancer Res 1986; 46: 3225–3238.

    Google Scholar 

  2. Paganelli G, Magnani P, Zito F, et al. Three-step monoclonal antibody tumor targeting in carcinoembryonic antigen-positive patients.Cancer Res 1991; 51: 5960–5966.

    Google Scholar 

  3. Paganelli G, Magnani P, Siccardi AG, et al. Clinical application of the avidin-biotin system for tumor targeting. In: Goldenberg DM, eds.Cancer therapy with radiolabeled antibodies. Boca Raton, FL.: CRC Press; 1995: 239–254.

    Google Scholar 

  4. Paganelli G, Chinol M, Grana C, et al. Optimization of the three-step pretargeting approach for diagnosis and therapy in cancer patients.J. Nucl Med 1995; 36: 225P.

    Google Scholar 

  5. Courtenay-Luck NS, Epenetos AA, Moore R, et al. Development of primary and secondary immune responses to mouse monoclonal antibodies used in the diagnosis and therapy of malignant neoplasms.Cancer Res 1986; 46: 6489–6493.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Nuclear Medicine, European Institute of Oncology, Milano, Italy

    Giovanni Paganelli, Marco Chinol & Monica Maggiolo

  2. DIBIT San Raffaele Scientific Institute, Milano, Italy

    Alessandro Sidoli, Angelo Corti, Stefano Baroni & Antonio G. Siccardi

Authors
  1. Giovanni Paganelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marco Chinol
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Monica Maggiolo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Alessandro Sidoli
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Angelo Corti
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Stefano Baroni
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Antonio G. Siccardi
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Paganelli, G., Chinol, M., Maggiolo, M. et al. The three-step pretargeting approach reduces the human anti-mouse antibody response in patients submitted to radioimmunoscintigraphy and radioimmunotherapy. Eur J Nucl Med 24, 350–351 (1997). https://doi.org/10.1007/BF01728778

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01728778

Keywords

Search

Navigation